Inpatient Urology Consult

PATIENT INFORMATION: - Name: John Doe - Date of Birth: 15 March 1965 - Medical Record Number: 123456789 - Date of Consultation: 1 November 2024 REFERRING PHYSICIAN: - Name: Dr. Emily Smith - Contact Information: emily.smith@hospital.org REASON FOR CONSULTATION: - Evaluation of recurrent urinary tract infections and hematuria. HISTORY OF PRESENT ILLNESS: - The patient, a 59-year-old male, presents with a history of recurrent urinary tract infections over the past six months, accompanied by episodes of hematuria. He reports dysuria and increased urinary frequency. No fever or flank pain noted. Previous treatments with antibiotics have provided temporary relief. PAST MEDICAL HISTORY: - Hypertension, Type 2 Diabetes Mellitus, Benign Prostatic Hyperplasia. PAST SURGICAL HISTORY: - Appendectomy in 1985, Transurethral Resection of the Prostate (TURP) in 2018. MEDICATIONS: - Lisinopril 10 mg daily, Metformin 500 mg twice daily, Tamsulosin 0.4 mg daily. ALLERGIES: - Penicillin (rash) SOCIAL HISTORY: - Smokes 10 cigarettes per day, occasional alcohol use, retired accountant. FAMILY HISTORY: - Father had prostate cancer. PHYSICAL EXAMINATION: - General: Alert, oriented, vital signs stable. - Abdomen: Soft, non-tender, no organomegaly. - Genitourinary: Mild tenderness over the bladder, no palpable masses. - Other: No peripheral edema. LABS AND IMAGING SYNTHESIS: - Urinalysis shows pyuria and hematuria. Ultrasound of the kidneys and bladder reveals no stones or masses. ASSESSMENT: - Recurrent urinary tract infections, likely secondary to benign prostatic hyperplasia. ICD-10 Codes: N39.0, N40.1 PLAN: - Initiate a course of ciprofloxacin for 7 days. Schedule a cystoscopy to evaluate for any underlying bladder pathology. Continue current medications for hypertension and diabetes. FOLLOWUP: - Follow-up in two weeks to review cystoscopy results and assess response to treatment. CONSULTANT UROLOGIST: - Name: Dr. Thomas Smith - Date: 11/01/2024 “Consent for the use of AI-assisted tools for documentation was obtained from the patient and all other participants in the visit prior to this encounter. All questions were answered. Patient understands that they may decline the use of AI-assisted tools.”